Is it time for microbiome-based therapies in viral infections?

Virus Res. 2021 Jan 2:291:198203. doi: 10.1016/j.virusres.2020.198203. Epub 2020 Oct 22.

Abstract

Infectious diseases related to viruses, as well as bacterial pathogens, abound in all parts of the world, burdening health and economy. Thus, there is a dire need to find new prevention and treatment strategies to improve clinical practices related to viral infections. Human gut contains trillions of bacteria which have regulatory roles in immune development, homeostasis, and body metabolism. Today, it is difficult to find any prominent viral infection that hasn't had any link with the human gut microbiota. In this opinion-based review article, I argued the significance of manipulating human gut microbiota as novel therapeutics through probiotics or FMT in alleviating complexities related to viral infections, and pinpointed bottlenecks involved in this research.

Keywords: Corona viruses; Gut microbiota; HIV; Probiotics; Viral infections.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Dysbiosis / etiology
  • Dysbiosis / therapy
  • Dysbiosis / virology
  • Gastrointestinal Microbiome
  • Humans
  • Mice
  • Microbiota / genetics*
  • Microbiota / immunology
  • Probiotics / therapeutic use*
  • Virus Diseases / immunology
  • Virus Diseases / therapy*